The independent source for health policy research, polling, and news.
121-140 of 278 results
Florida has served as a haven for Southern pregnant women with little or no access to abortions. But the Florida Supreme Court upheld a six-week abortion restriction that begins in May — so now women across much of the South seeking abortions will have to look farther afield.
Some tax filers’ returns are being rejected because they failed to provide information about Affordable Care Act coverage they didn’t even know they had.
The broad availability of over-the-counter dental products containing fluoride has some community leaders arguing that its addition to public drinking water is no longer necessary. But public health experts worry that, much like vaccines, fluoridation may be a victim of its own success.
Most of the doctors the FDA tapped to advise it on an Abbott medical device had financial ties to the company. The FDA didn’t disclose the payments.
Insurance agents say it’s too easy to access consumer information on the Affordable Care Act federal marketplace. Policyholders can lose their doctors and access to prescriptions. Some end up owing back taxes.
Disputes between hospitals and Medicare Advantage plans are leading to entire hospital systems suddenly leaving insurance networks. Patients are left stuck in the middle, choosing between their doctors and their insurance plan. There’s a way out.
Ballad Health was granted the nation’s largest state-sanctioned hospital monopoly in 2018. Since then, its emergency rooms have become more than three times as slow.
A recently unsealed lawsuit alleges Aledade Inc. developed billing software that boosted revenues by making patients appear sicker than they were.
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
While many Republican state lawmakers remain firmly against Medicaid expansion, some key leaders in holdout states are showing a willingness to reconsider. Public opinion, financial incentives, and widening health care needs make resistance harder.
Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they’ll pay for patients’ drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.
After the U.S. Supreme Court ended the federal right to an abortion and many states banned the procedure, reproductive health care organizations hired dozens of people to help patients arrange travel and pay for care.
Hundreds of thousands of Americans become disabled or die each year because of a diagnostic error. But some patients are at higher risk than others.
Federal officials have long warned that restraint and seclusion in schools can be dangerous and traumatizing for children, but school districts often fail to report incidents as required by law.
Even in states where laws protect minors’ access to gender-affirming care, malpractice insurance premiums are keeping small and independent clinics from treating patients.
Adults who develop one autoimmune form of diabetes are often misdiagnosed with Type 2 diabetes. Those wrong diagnoses make it harder to get the appropriate medications and technology to manage their blood sugar. Many Black patients wonder if their race plays a role.
Even people with good insurance aren't guaranteed affordable care, as this Ñî¹óåú´«Ã½Ò•îl Health News follow-up to one patient’s saga shows.
Delaying cancer treatment can be deadly — which makes the roadblock-riddled process that health insurers use to approve or deny care particularly daunting for oncology patients.
As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?
© 2026 KFF